000281277 001__ 281277
000281277 005__ 20251005002027.0
000281277 0247_ $$2doi$$a10.1002/bsa3.70032
000281277 0247_ $$2altmetric$$aaltmetric:181429655
000281277 037__ $$aDZNE-2025-01092
000281277 082__ $$a610
000281277 1001_ $$0P:(DE-2719)2814122$$aWirth, Miranka$$b0$$eFirst author
000281277 245__ $$aREMINDer randomized controlled study: Feasibility and impact of an online multimodal mind–body intervention in older adults
000281277 260__ $$aHoboken, NJ$$bWiley$$c2025
000281277 3367_ $$2DRIVER$$aarticle
000281277 3367_ $$2DataCite$$aOutput Types/Journal article
000281277 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1759233828_23816
000281277 3367_ $$2BibTeX$$aARTICLE
000281277 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000281277 3367_ $$00$$2EndNote$$aJournal Article
000281277 500__ $$aMissing Journal: Alzheimer's & Dementia: Behavior & Socioeconomics of Aging (Alzheimer's & Dementia: Behavior & Socioeconomics of Aging) = 2997-3805 (import from CrossRef, Journals: pub.dzne.de)
000281277 520__ $$aINTRODUCTION: The increasing prevalence of age-related diseases, includingAlzheimer’s disease, underscores the need for accessible, cost-effective lifestyleinterventions to reduce modifiable dementia risk factors and support healthy aging.METHODS: REMINDer is a randomized controlled pilot trial evaluating the feasi-bility and impact of a 6-week online, home-based, live-streamed multimodal groupintervention delivered via videoconferencing. The program, designed for older adults,integrates music, dance movement, and mindfulness. Using a cross-over design (AB-BA), participants (N = 50) are randomized to receive the intervention with two 60-minsessions per week or a passive control (with delayed intervention).RESULTS: Digital outcome assessments were conducted remotely at baseline, post-intervention, and follow-up. Primary outcomes include feasibility (adherence rate)and changes in mental and physical well-being (SF-12). Secondary outcomes includechanges in multi-domain health and lifestyle behaviors.DISCUSSION: REMINDer will provide evidence on the feasibility and preliminary effec-tiveness of a scalable online multimodal intervention to support healthy aging andreduce dementia risk.
000281277 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000281277 588__ $$aDataset connected to CrossRef, Journals: pub.dzne.de
000281277 7001_ $$0P:(DE-2719)9002956$$aStamer, Selina$$b1
000281277 7001_ $$0P:(DE-2719)2814781$$aPodolski, Odile-Sophie$$b2
000281277 7001_ $$0P:(DE-2719)9002946$$aMaßalsky, Annemarie$$b3
000281277 7001_ $$aKoch, Sabine C.$$b4
000281277 7001_ $$0P:(DE-2719)9002456$$aKlimecki, Olga$$b5$$eLast author
000281277 773__ $$0PERI:(DE-600)2201940-6$$a10.1002/bsa3.70032$$gVol. 1, no. 3, p. e70032$$n3$$pe70032$$tAlzheimer's and dementia$$v1$$x1552-5260$$y2025
000281277 8564_ $$uhttps://pub.dzne.de/record/281277/files/DZNE-2025-01092%20SUP.pdf
000281277 8564_ $$uhttps://pub.dzne.de/record/281277/files/DZNE-2025-01092.pdf$$yOpenAccess
000281277 8564_ $$uhttps://pub.dzne.de/record/281277/files/DZNE-2025-01092%20SUP.pdf?subformat=pdfa$$xpdfa
000281277 8564_ $$uhttps://pub.dzne.de/record/281277/files/DZNE-2025-01092.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000281277 909CO $$ooai:pub.dzne.de:281277$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000281277 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2814122$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000281277 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9002956$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b1$$kDZNE
000281277 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2814781$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b2$$kDZNE
000281277 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9002946$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b3$$kDZNE
000281277 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9002456$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b5$$kDZNE
000281277 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000281277 9141_ $$y2025
000281277 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-06
000281277 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-06
000281277 915__ $$0LIC:(DE-HGF)CCBYNCND4$$2HGFVOC$$aCreative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
000281277 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bALZHEIMERS DEMENT : 2022$$d2025-01-06
000281277 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2025-01-06$$wger
000281277 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-01-06
000281277 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bALZHEIMERS DEMENT : 2022$$d2025-01-06
000281277 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-06
000281277 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000281277 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-01-06
000281277 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2025-01-06
000281277 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-06
000281277 920__ $$lyes
000281277 9201_ $$0I:(DE-2719)1710011$$kAG Wirth$$lBrain Resilience$$x0
000281277 980__ $$ajournal
000281277 980__ $$aVDB
000281277 980__ $$aUNRESTRICTED
000281277 980__ $$aI:(DE-2719)1710011
000281277 9801_ $$aFullTexts